This activity is expired and is no longer available for CME credit.


Emerging Therapies in Neovascular Retinal Disease – Featuring Wheel of Knowledge

Author(s)/Faculty: Peter A. Campochiaro, MD; Arshad M. Khanani, MD, MA; Charles C. Wykoff, MD, PhD
Release Date: 2/6/2020Expiration Date: 2/5/2021
Credit Type: CMENumber of Credits: 0
Content Type: LectureProvider:
Outcomes for patients with neovascular retinal disease have been revolutionized by the integration of intravitreal anti-vascular endothelial growth factor (anti-VEGF) therapy into management protocols. However, approximately two-thirds of patients receive a suboptimal response to anti-VEGF therapy. For those who respond to treatment, the individualization of dosing schedules to maintain visual acuity gains can be challenging and burdensome to the patient. To further enhance visual outcomes and reduce treatment burden, there is a need to discover and classify novel molecular pathways for targeted therapeutic intervention as well as novel methods for sustained delivery. In this recorded satellite symposium, experts review the evidence regarding the long-term effectiveness of current treatments, assess the mechanisms of novel treatments that target alternate pathways as well as those that offer medication delivery for extended periods of time, and evaluate new findings for these novel therapies that may improve treatment for patients with neovascular retinal disease.